Brett Laflamme

Brett LaFlamme is an experienced marketing and operations professional specializing in oncology, currently serving as the Oncology Commercial Performance and Operations Lead at Ipsen since April 2023. Previous roles include Senior Director of Marketing and Director of Tazemetostat Marketing at Epizyme, Associate Director of HCP Marketing at Agios Pharmaceuticals, and various marketing positions at Merrimack Pharmaceuticals, Insulet Corporation, Biogen Idec, ARIAD Pharmaceuticals, and AMAG Pharmaceuticals, where Brett developed numerous marketing strategies, managed budgets, and led product launches. Early career experience includes a legislative aide position at the State House. Brett holds a BA in Philosophy from Bates College, obtained in 2004.